Related references
Note: Only part of the references are listed.Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis
Pei-Jie Chen et al.
BIOCHIMIE (2015)
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Satdarshan Pal Monga
GASTROENTEROLOGY (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway
Xiang Lin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Hepatic fibrosis: Concept to treatment
Christian Trautwein et al.
JOURNAL OF HEPATOLOGY (2015)
DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
Yu Liu et al.
ONCOTARGET (2015)
Epigenetic Modifications in Fibrotic Diseases: Implications for Pathogenesis and Pharmacological Targets
Hong-Wei Yao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells
J. Bai et al.
CELL PROLIFERATION (2014)
Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation
Xu Sun et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Canonical and non-canonical roles of the histone methyltransferase EZH2 in mammary development and cancer
Woo Kyun Bae et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation
Wen-Song Ge et al.
MOLECULAR MEDICINE REPORTS (2014)
EZH2 as a potential target in cancer therapy
Michael T. McCabe et al.
EPIGENOMICS (2014)
MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases
Yong He et al.
BIOCHIMIE (2013)
Wnt signaling in liver fibrosis: Progress, challenges and potential directions
Cheng-gui Miao et al.
BIOCHIMIE (2013)
DNA methylation: New therapeutic implications for hepatic fibrosis
Er-Bao Bian et al.
CELLULAR SIGNALLING (2013)
Involvement of the Wnt/β-Catenin Signaling Pathway in the Cellular and Molecular Mechanisms of Fibrosis in Endometriosis
Sachiko Matsuzaki et al.
PLOS ONE (2013)
The role of methyl-CpG binding protein 2 in liver fibrosis
Er-Bao Bian et al.
TOXICOLOGY (2013)
TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways
Ling Fang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Secreted and Transmembrane Wnt Inhibitors and Activators
Cristina-Maria Cruciat et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Alfiya Akhmetshina et al.
NATURE COMMUNICATIONS (2012)
MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis
Jelena Mann et al.
GASTROENTEROLOGY (2010)
Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells
Mustafa Hussain et al.
CANCER RESEARCH (2009)
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
Jason H. Cheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
Hepatic fibrogenesis
Jinsheng Guo et al.
SEMINARS IN LIVER DISEASE (2007)
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27
A Kirmizis et al.
GENES & DEVELOPMENT (2004)
Share Paper
